Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

928 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiotherapy for localized hormone-refractory prostate cancer in Japan.
Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Shioyama Y, Inoue T; Japanese PCS Working Subgroup of Prostate Cancer. Nakamura K, et al. Among authors: imai a. Anticancer Res. 2004 Sep-Oct;24(5B):3141-5. Anticancer Res. 2004. PMID: 15510602 Free article.
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K. Koie T, et al. Among authors: imai a. Int J Clin Oncol. 2016 Apr;21(2):379-383. doi: 10.1007/s10147-015-0880-x. Epub 2015 Jul 30. Int J Clin Oncol. 2016. PMID: 26223693
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y. Fujita N, et al. Among authors: imai a. Int J Clin Oncol. 2017 Dec;22(6):1087-1093. doi: 10.1007/s10147-017-1160-8. Epub 2017 Jul 5. Int J Clin Oncol. 2017. PMID: 28681153 Clinical Trial.
Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.
Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y. Koie T, et al. Among authors: imai a. World J Surg Oncol. 2014 Apr 30;12:134. doi: 10.1186/1477-7819-12-134. World J Surg Oncol. 2014. PMID: 24885947 Free PMC article.
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C. Fujita N, et al. Among authors: imai a. Clin Genitourin Cancer. 2020 Oct;18(5):e523-e530. doi: 10.1016/j.clgc.2020.03.009. Epub 2020 Mar 13. Clin Genitourin Cancer. 2020. PMID: 32278839
928 results